𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Obstructive Sleep Apnea and Hypopnea Efficacy and Safety of a Long-Acting β2-Agonist

✍ Scribed by Kurt Rasche; Hans-Werner Duchna; Julia Lauer; Maritta Orth; Sylvia Kotterba; Torsten Thomas Bauer; Adrian Gillissen; Gerhard Schultze-Werninghaus

Publisher
Springer-Verlag
Year
1999
Tongue
English
Weight
68 KB
Volume
3
Category
Article
ISSN
1520-9512

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term tolerability and efficacy of c
Long-term tolerability and efficacy of cabergoline, a new long-acting dopamine agonist, in Parkinson's disease
✍ R. Inzelberg; P. Nisipeanu; M. J. Rabey; Prof. A. D. Korczyn 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB 👁 2 views

## Abstract Motor fluctuations constitute a severe complication of chronic levodopa therapy. The addition of dopamine agonists may partially alleviate these responses; however, due to the short half‐lefe of these drugs, several daily doses are required. Cabergoline is a new dopamine agonist with a

Efficacy and safety of long-acting rispe
Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder
✍ Robert A. Lasser; Cynthia A. Bossie; Young Zhu; Georges Gharabawi; Mariëlle Eerd 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

## Abstract ## Background Elderly patients are often an underserved population in terms of optimizing treatment outcomes. Long‐acting risperidone, the first long‐acting injectable atypical antipsychotic, can improve outcomes through continuous medication delivery. ## Objective To assess the effi